Skip to content

Clinical trials

Phase 4 Hyperlipidemias trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 4 Country / region: South Korea Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20131
20141
20151
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University2
Dong-A ST Co., Ltd.1
HK inno.N Corporation1
Hanmi Pharmaceutical Company Limited1
JW Pharmaceutical1
Korea University Anam Hospital1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias8
Atherosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Coronary Disease1
Dyslipidemias1
Hypertension1
Renal Insufficiency, Chronic1
Ventricular Dysfunction, Left1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.